Market Cap (In CNY)
6.98 Billion
Revenue (In CNY)
1.45 Billion
Net Income (In CNY)
-106.48 Million
Avg. Volume
78.57 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.83-7.11
- PE
- -18.24
- EPS
- -0.29
- Beta Value
- 0.473
- ISIN
- CNE0000004W8
- CUSIP
- -
- CIK
- -
- Shares
- 1336176917.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Junhong Wang
- Employee Count
- -
- Website
- https://www.haiyao.com.cn
- Ipo Date
- 1994-05-25
- Details
- Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor medicine series, cochlear implant series, etc.; and vitamin C for injection scurvy, idiopathic methemoglobinemia, etc. The company also provides internet medical treatment and medical services. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.
More Stocks
-
161390
-
002925Xiamen Intretech Inc.
002925
-
DLEDatalex plc
DLE
-
BLHWFBELIMO Holding AG
BLHWF
-
KNM
-
002177
-
YOSHYoshiharu Global Co.
YOSH
-
6020